Swiggy share price: Swiggy shares rose 4% after UBS initiated coverage with a ‘buy’ rating and target price of Rs 515, citing growth potential in online food delivery and quick commerce amid improving margins.
Emcure Pharma shares advance 10% as Kotak Equities sees 28% upside in stock
Driven by strong organic growth, an in-licensing agreement with Sanofi, the consolidation of Mantra, and the resolution of most legal challenges, Emcure is projected to